Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AVB-S6-500
AVB-S6-500
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
CP Wire
Mon, 08/20/18 - 09:58 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
Mon, 08/20/18 - 09:44 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
